Direct answer: Kelly Clarkson said in her May 2024 conversation with Whoopi Goldberg that she used prescription medication and that it was not Ozempic. She did not name the medication in that statement. Identifying it as metformin, levothyroxine or a combination, as the earlier article did, goes beyond the available disclosure.
Separate Clarkson's statement from Goldberg's statement
The conversation involved two speakers discussing their own experiences. A medication named by one guest is not automatically the host's medication. The dated recording and its attribution matter more than a headline grouping both people together.
| Claim | Evidence in the May 2024 conversation | Accurate interpretation |
|---|---|---|
| Clarkson used prescription medication. | She acknowledged this herself. | Prescription use is part of that public account. |
| Her medication was Ozempic. | She said it was not. | Do not attribute Ozempic to her from this conversation. |
| Her medication was metformin or thyroid replacement. | She did not name the product. | Those names were editorial guesses, not verified disclosures. |
| Another speaker named a drug. | The recording includes another person's account. | Keep each statement attached to its speaker. |
A description of a medicine's effect does not identify its brand
A person's everyday description of what a medicine does is not a drug-identification test. Different treatments can be discussed using similar words. Filling in a product name from a brief description creates certainty the statement did not provide.
The previous article also used diagnoses and hypothetical mechanisms to rank possible medications. That ranking is removed. A source check can establish who spoke, what they actually named and when they said it; it cannot reconstruct an undisclosed prescription.
FAQ: Questions about Kelly Clarkson's disclosure
Did she acknowledge medication use?
Yes, in the May 2024 conversation reviewed here.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →Did she name a replacement for Ozempic?
No product name is established by the cited statement.
Does saying it was not Ozempic rule out every GLP-1 medicine?
No. A denial of one named product is narrower than a statement about an entire drug class.
Source recording
Footer disclaimers
Platform Disclaimer. FormBlends serves as a digital health platform linking patients with independent licensed clinicians and U.S.-licensed pharmacies. We do not manufacture, prescribe, or fill medications directly. All clinical decisions rest with the licensed provider after their individual evaluation of the patient.
Compounded Medication Notice. Compounded semaglutide and compounded tirzepatide are not FDA-approved. State-licensed 503A pharmacies prepare them for individual patients under physician prescription. Compounded formulations have not undergone the FDA review applied to brand-name drugs and should not be regarded as equivalents to brand medications.
Results Disclaimer. Outcomes vary between individuals. Weight changes depend on diet, training, sleep, adherence, baseline metabolic status, and other variables. Statistics cited from clinical trials reflect study averages and may differ from real-world results. Kelly Clarkson's described outcome reflects her specific medical situation, including her thyroid and pre-diabetes diagnoses, and is not predictive of outcomes for other patients.
Trademark Notice. Ozempic, Wegovy, and Rybelsus are registered trademarks of Novo Nordisk A/S. Mounjaro and Zepbound are registered trademarks of Eli Lilly and Company. Trulicity is a registered trademark of Eli Lilly. Jardiance is a registered trademark of Boehringer Ingelheim Pharmaceuticals. Farxiga is a registered trademark of AstraZeneca. FormBlends is not affiliated with Kelly Clarkson, NBC, The Kelly Clarkson Show, or any company referenced in this article.
See your options in about 2 minutes
Take the free quiz and see what fits you. Quick, private, and no commitment to continue.
See my options →